NL-OMON48185RecruitingNot Applicable
Dissection of the blood B cell compartment in affected and non-affected family members of patients with Common Variable Immunodeficiency (CVID). - Blood B cell compartment in CVID families
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 2 to 99 (—)
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:;Inclusion criteria for the index case
- •- ESID-defined probable or possible CVID patients with or without positive family history for CVID according to the ESID registry (2014) criteria;Inclusion criteria for the family members
- •- Siblings (> 16 years of age), parents and grandparents
- •- Each participating family member will have to provide informed consent in order for the family to be eligible for inclusion.
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •- ESID-defined CVID patients having a known mono-genetic cause of CVID disease
- •- ESID-defined CVID patients having another mono-genetic disorder not obvious related to CVID
- •- ESID-defined CVID patients having a chromosomal defect
- •- Infections within 3 months prior to this study
- •- Surgeries within 6 months prior to this study
- •- Vaccinations within 3 months prior to this study
- •- Family members having significant disorders, including other immunodeficiency other than CVID, cancer, oral steroid therapy or any history of any comorbidity that, in the opinion of the investigator, might confound the results of the study
Investigators
Similar Trials
Completed
Not Applicable
The function and composition of B cells in patients with Glioblastoma treated with and without Dexamethasone10029211GlioblastomaBrain TumorNL-OMON49155Vrije Universiteit Medisch Centrum20
Recruiting
Phase 3
Single-cell deep phenotyping of B lymphocytes to personalize immunotherapy in patients with Myasthenia Gravis: clinical trial to evaluate the efficacy and safety of Rituximab in generalized AChR-antibody positive Myasthenia GravisGeneralized Myasthenia Gravis2024-518939-12-00Fondazione Policlinico Universitario Agostino Gemelli IRCCS40
Completed
Not Applicable
The elucidation of the mechanism of the B-cell tolerance in the minor ABO-mismatched bone marrow transplantatioJPRN-UMIN000005842Keio University School of Medicine10
Suspended
Not Applicable
Determining functional B cell response in lung canceron-Small Cell Lung CancerCancerISRCTN49173282niversity of Birmingham40
Completed
Not Applicable
Isolation and immune profiling of human B lymphocytes for the development of potential diagnostic and therapeutic antibodiesendometrial cancerUterine cancer10038594NL-OMON55081niversitair Medisch Centrum Groningen67